| scholarly article | Q13442814 |
| P2093 | author name string | Dany Anglicheau | |
| Maarten Naesens | |||
| P2860 | cites work | Recurrent IgA Nephropathy After Kidney Transplantation. | Q30251891 |
| Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation. | Q33409714 | ||
| EpViX: A cloud-based tool for epitope reactivity analysis and epitope virtual crossmatching to identify low immunologic risk donors for sensitized recipients | Q33445744 | ||
| Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates | Q33993597 | ||
| Urinary-cell mRNA profile and acute cellular rejection in kidney allografts | Q34037420 | ||
| Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation | Q34124202 | ||
| Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. | Q34260097 | ||
| Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study | Q34483895 | ||
| Immunosuppressive Medications | Q34484801 | ||
| The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study | Q34489123 | ||
| Calcineurin inhibitor nephrotoxicity | Q34945314 | ||
| Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. | Q35027253 | ||
| A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation | Q35379384 | ||
| Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling. | Q35629098 | ||
| Biomarkers and surrogate endpoints in clinical trials | Q36552129 | ||
| Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy | Q37042246 | ||
| Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching | Q37252505 | ||
| The elephant in the room: failings of current clinical endpoints in kidney transplantation | Q37737362 | ||
| Molecular diagnostics in transplantation. | Q37782254 | ||
| Management of cytomegalovirus infection in solid organ transplantation | Q37803335 | ||
| Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation. | Q37865364 | ||
| Management of polyomavirus-associated nephropathy in renal transplant recipients | Q38003050 | ||
| Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation | Q38125063 | ||
| Recurrence of glomerulonephritis after renal transplantation. | Q38129623 | ||
| Pretransplant identification of acute rejection risk following kidney transplantation | Q38151922 | ||
| Biomarkers for kidney transplant rejection | Q38180358 | ||
| MicroRNAs as biomarkers of graft outcome | Q38209466 | ||
| Histopathology of MPGN and C3 glomerulopathies | Q38275117 | ||
| Urinary biomarkers of renal transplant outcome. | Q38536979 | ||
| Biomarkers to assess donor-reactive T-cell responses in kidney transplant patients | Q38568058 | ||
| Primary glomerulonephritides | Q38752824 | ||
| Urinary MicroRNA as Biomarker in Renal Transplantation. | Q38811436 | ||
| Molecular assessment of disease states in kidney transplant biopsy samples | Q38877380 | ||
| Evidence for an important role of both complement-binding and noncomplement-binding donor-specific antibodies in renal transplantation. | Q38878451 | ||
| Strategic Use of Epitope Matching to Improve Outcomes | Q38881677 | ||
| Establishing Biomarkers in Transplant Medicine: A Critical Review of Current Approaches. | Q38914846 | ||
| Molecular diagnosis of antibody-mediated rejection in human kidney transplants | Q39466553 | ||
| A molecular classifier for predicting future graft loss in late kidney transplant biopsies | Q39869686 | ||
| Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. | Q39904553 | ||
| Belatacept and Long-Term Outcomes in Kidney Transplantation | Q40055241 | ||
| Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study | Q41035928 | ||
| The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. | Q42174325 | ||
| Post-transplant renal function in the first year predicts long-term kidney transplant survival | Q44039650 | ||
| Poor predictive value of serum creatinine for renal allograft loss | Q44663038 | ||
| Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study. | Q45057936 | ||
| Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
| Complement-binding anti-HLA antibodies and kidney-allograft survival | Q46141053 | ||
| The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens | Q47683551 | ||
| Urinary mRNA for the Diagnosis of Renal Allograft Rejection: The Issue of Normalization | Q48220293 | ||
| Should epitope-based HLA compatibility be used in the kidney allocation system? | Q51368994 | ||
| Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes. | Q51775005 | ||
| Foretelling Graft Outcome by Molecular Evaluation of Renal Allograft Biopsies: The GoCAR Study. | Q53781355 | ||
| HLA-DR and -DQ Eplet Mismatches and Transplant Glomerulopathy: A Nested Case-Control Study | Q63244396 | ||
| Advances in the understanding of complement mediated glomerular disease: implications for recurrence in the transplant setting | Q86580391 | ||
| P433 | issue | 1 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 24-34 | |
| P577 | publication date | 2017-10-09 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Precision Transplant Medicine: Biomarkers to the Rescue | |
| P478 | volume | 29 |
| Q92039650 | A Test Identifying Biomarkers of Immunosuppression-Related Adverse Events in Kidney Transplant Recipients |
| Q60311100 | A composite of urinary biomarkers for differentiating between tubulointerstitial inflammation and interstitial fibrosis/tubular atrophy in kidney allografts |
| Q92311964 | A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring |
| Q55332434 | Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer. |
| Q89746966 | Evaluation and Treatment of Acute Rejection in Kidney Allografts |
| Q90632963 | Kidney Perfusion as an Organ Quality Assessment Tool-Are We Counting Our Chickens Before They Have Hatched? |
| Q92755551 | Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives |
| Q99604948 | Urinary Biomarkers for Diagnosis and Prediction of Acute Kidney Allograft Rejection: A Systematic Review |
Search more.